Charlie Petty - Principal and Co-Founder @ Adjuvant Capital

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Just Appraised	No	Seed Round - Just Appraised	obfuscated obfuscation
obfuscated obfuscation	Digital Alloys	—	Series A - Digital Alloys	obfuscated obfuscation
obfuscated obfuscation	New Valence Robotics Corporation	—	Convertible Note - New Valence Robotics Corporation	obfuscated obfuscation

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	VitriVax	Adjuvant Capital	Yes	Series B - VitriVax	obfuscated obfuscation
obfuscated obfuscation	Curevo	Adjuvant Capital	—	Series B - Curevo	obfuscated obfuscation
obfuscated obfuscation	Codagenix	Adjuvant Capital	—	Series B - Codagenix	obfuscated obfuscation
obfuscated obfuscation	Curevo	Adjuvant Capital	—	Series A - Curevo	obfuscated obfuscation
obfuscated obfuscation	Endpoint Health	Global Health Investment Fund (GHIF)	—	Series A - Endpoint Health	obfuscated obfuscation
obfuscated obfuscation	Curevo	Adjuvant Capital	—	Series A - Curevo	obfuscated obfuscation
obfuscated obfuscation	VitriVax	Adjuvant Capital	Yes	Series A - VitriVax	obfuscated obfuscation
obfuscated obfuscation	Alydia Health	Global Health Investment Fund (GHIF)	—	Series C - Alydia Health	obfuscated obfuscation
obfuscated obfuscation	ChromaCode	Adjuvant Capital	Yes	Series C - ChromaCode	obfuscated obfuscation
obfuscated obfuscation	Codagenix	Adjuvant Capital	Yes	Series B - Codagenix	obfuscated obfuscation

Number of Exits

has

obfuscation

exit -

has

obfuscation

exits. Their most notable exits are

New Valence Robotics Corporation NVBOTS creates automated, enterprise 3D printing solutions that fix industry’s toughest problems.

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Principal and Co-Founder

and

Managing Director

. Additionally,

has had

past jobs including

Associate

Organization Name	Title At Company	Start Date	End Date
Global Health Investment Fund (GHIF)	Associate	Jan 2017	Sep 2018
Artemis Capital Partners	Associate	Dec 2013	Dec 2016

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
New York Convertible Note Investors	69,895
Greater New York Area Late Stage Venture Investors	24,962
Convertible Note Investors with Investments in New York	28,871
Late Stage Venture Investors with Investments in New York	5,735
Convertible Note Investors with Investments in United States	20,919
Northeastern US Post IPO Investors	66,280
Convertible Note Investors with Investments in Northeastern US	29,263
Post IPO Investors with Investments in United States	18,966
East Coast Venture Stage Investors	30,898
Northeastern US Venture Stage Investors	38,774